Reduced Immunity Regulator MAVS Contributes to Non-Hypertrophic Cardiac Dysfunction by Disturbing Energy Metabolism and Mitochondrial Homeostasis
Open Access
- 1 July 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 919038
Abstract
Cardiac dysfunction is manifested as decline of cardiac systolic function, and multiple cardiovascular diseases (CVDs) can develop cardiac insufficiency. Mitochondrial antiviral signaling (MAVS) is known as an innate immune regulator involved in viral infectious diseases and autoimmune diseases, whereas its role in the heart remains obscure. The alteration of MAVS was analyzed in animal models with non-hypertrophic and hypertrophic cardiac dysfunction. Then, MAVS-deficient mice were generated to examine the heart function, mitochondrial status and energy metabolism. In vitro, CRISPR/Cas9-based gene editing was used to delete MAVS in H9C2 cell lines and the phenotypes of mitochondria and energy metabolism were evaluated. Here we observed reduced MAVS expression in cardiac tissue from several non-hypertrophic cardiac dysfunction models, contrasting to the enhanced MAVS in hypertrophic heart. Furthermore, we examined the heart function in mice with partial or total MAVS deficiency and found spontaneously developed cardiac pump dysfunction and cardiac dilation as assessed by echocardiography parameters. Metabonomic results suggested MAVS deletion probably promoted cardiac dysfunction by disturbing energy metabolism, especially lipid metabolism. Disordered and mitochondrial homeostasis induced by mitochondrial oxidative stress and mitophagy impairment also advanced the progression of cardiac dysfunction of mice without MAVS. Knockout of MAVS using CRISPR/Cas9 in cardiomyocytes damaged mitochondrial structure and function, as well as increased mitochondrial ROS production. Therefore, reduced MAVS contributed to the pathogenesis of non-hypertrophic cardiac dysfunction, which reveals a link between a key regulator of immunity (MAVS) and heart function.Keywords
This publication has 44 references indexed in Scilit:
- Parkin Protein Deficiency Exacerbates Cardiac Injury and Reduces Survival following Myocardial InfarctionJournal of Biological Chemistry, 2013
- Chronic creatine kinase deficiency eventually leads to congestive heart failure, but severity is dependent on genetic background, gender and ageBasic Research in Cardiology, 2012
- The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarctionJournal of Clinical Investigation, 2011
- PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart functionProceedings of the National Academy of Sciences, 2011
- A loss‐of‐function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patientsEMBO Molecular Medicine, 2011
- Myocardial Fatty Acid Metabolism in Health and DiseasePhysiological Reviews, 2010
- Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndromeJournal of Lipid Research, 2009
- The creatine kinase energy transport system in the failing mouse heartJournal of Molecular and Cellular Cardiology, 2007
- Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heartThe FASEB Journal, 2004
- The Creatine Kinase System in Normal and Diseased Human MyocardiumNew England Journal of Medicine, 1985